Nanostructured lipid carriers system: Recent advances in drug delivery

被引:295
作者
Iqbal, Md Asif [1 ]
Md, Shadab [1 ]
Sahni, Jasjeet Kaur [1 ]
Baboota, Sanjula [1 ]
Dang, Shweta [2 ]
Ali, Javed [1 ]
机构
[1] Jamia Hamdard, Fac Pharm, Dept Pharmaceut, New Delhi 110062, India
[2] Jaypee Inst Informat Technol, Dept Biotechnol, Noida, India
关键词
Nanostructured lipid carriers; drug delivery; lipid; colloidal carrier; surfactants; ALPHA-LIPOIC ACID; NANOPARTICLES SLN; IN-VITRO; TOPICAL DELIVERY; ORAL BIOAVAILABILITY; PHYSICOCHEMICAL CHARACTERIZATION; PERCUTANEOUS-ABSORPTION; PROCESS PARAMETERS; LOCAL-ANESTHESIA; OCULAR DELIVERY;
D O I
10.3109/1061186X.2012.716845
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanostructured lipid carrier (NLC) is second generation smarter drug carrier system having solid matrix at room temperature. This carrier system is made up of physiological, biodegradable and biocompatible lipid materials and surfactants and is accepted by regulatory authorities for application in different drug delivery systems. The availability of many products in the market in short span of time reveals the success story of this delivery system. Since the introduction of the first product, around 30 NLC preparations are commercially available. NLC exhibit superior advantages over other colloidal carriers viz., nanoemulsions, polymeric nanoparticles, liposomes, SLN etc. and thus, have been explored to more extent in pharmaceutical technology. The whole set of unique advantages such as enhanced drug loading capacity, prevention of drug expulsion, leads to more flexibility for modulation of drug release and makes NLC versatile delivery system for various routes of administration. The present review gives insights on the definitions and characterization of NLC as colloidal carriers including the production techniques and suitable formulations. This review paper also highlights the importance of NLC in pharmaceutical applications for the various routes of drug delivery viz., topical, oral, pulmonary, ocular and parenteral administration and its future perspective as a pharmaceutical carrier.
引用
收藏
页码:813 / 830
页数:18
相关论文
共 113 条
[1]   Design and production of nanoparticles formulated from nano-emulsion templates-A review [J].
Anton, Nicolas ;
Benoit, Jean-Pierre ;
Saulnier, Patrick .
Journal of Controlled Release, 2008, 128 (03) :185-199
[2]  
Benson Heather Ae, 2005, Ther Clin Risk Manag, V1, P209
[3]  
Bilska A, 2005, PHARMACOL REP, V57, P570
[4]   Crystallization tendency and polymorphic transitions in triglyceride nanoparticles [J].
Bunjes, H ;
Westesen, K ;
Koch, MHJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :159-173
[5]   Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin [J].
Cavalli, R ;
Gasco, MR ;
Chetoni, P ;
Burgalassi, S ;
Saettone, MF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 238 (1-2) :241-245
[6]   Phase transition water-in-oil microemulsions as ocular drug delivery systems: In vitro and in vivo evaluation [J].
Chan, Judy ;
El Maghraby, Gamal M. M. ;
Craig, Jennifer P. ;
Alany, Raid G. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 328 (01) :65-71
[7]   Preparation of solid lipid nanoparticles using a membrane contactor [J].
Charcosset, C ;
El-Harati, A ;
Fessi, H .
JOURNAL OF CONTROLLED RELEASE, 2005, 108 (01) :112-120
[8]   Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH [J].
Charman, WN ;
Porter, CJH ;
Mithani, S ;
Dressman, JB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :269-282
[9]  
Charman WN, 2000, J PHARM SCI-US, V89, P967, DOI 10.1002/1520-6017(200008)89:8<967::AID-JPS1>3.0.CO
[10]  
2-R